To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene BLOC1S3andMARK4TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
308 supporting clones for gene BLOC1S3andMARK4 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AB049127 brain .a 1 to 3607 1 to 3608 F169S tiling clone,   3608/3609
(99 %)
4 diff
(99.9 %id)
AB058763 brain .a 293 to 5209 1 to 4917   tiling clone, available from KIAA,   4917/4917
(100 %)
1 diff
(100.0 %id)
NM_031417.2   .a 293 to 5209 1 to 4917   RefSeq,   4917/4917
(100 %)
1 diff
(100.0 %id)
CU442962 epidermis .a 317 to 601 1 to 283       283/298
(94 %)
7 diff
(97.7 %id)
CD633133   .a 325 to 956 1 to 635       635/635
(100 %)
6 diff
(99.1 %id)
DA805654 brain .a 345 to 888 2 to 545   capped   544/544
(100 %)
3 diff
(99.5 %id)
DA778072 brain .a 347 to 811 89 to 553   capped   465/552
(84 %)
6 diff
(99.0 %id)
CD633132   .a 406 to 1149 743 to 1       743/743
(100 %)
5 diff
(99.4 %id)
BF686388 leiomyosarcoma cell line, uterus .a 423 to 1151 1 to 719       719/720
(99 %)
12 diff
(98.4 %id)
DA401218 thalamus .a 435 to 984 2 to 552   capped   551/551
(100 %)
13 diff
(97.7 %id)
CD633134   .a 457 to 914 1 to 458       458/458
(100 %)
0 diff
(100 %id)
CD633135   .a 457 to 921 467 to 2       466/467
(99 %)
1 diff
(99.8 %id)
CD633136   .a 457 to 878 421 to 1       421/421
(100 %)
2 diff
(99.6 %id)
CD633137   .a 457 to 878 1 to 422       422/422
(100 %)
1 diff
(99.8 %id)
CD633138   .a 457 to 878 422 to 1       422/422
(100 %)
3 diff
(99.3 %id)
CD633139   .a 457 to 921 1 to 469       468/470
(99 %)
9 diff
(98.1 %id)
DA121943 cerebellum .a 492 to 1013 2 to 523   capped   522/522
(100 %)
1 diff
(99.9 %id)
CD633144   .a 504 to 1013 1 to 514       514/516
(99 %)
8 diff
(98.5 %id)
CD633147   .a 504 to 1369 1 to 871       871/879
(99 %)
21 diff
(97.7 %id)
DB139696 thymus .a 507 to 1049 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
CD633145   .a 511 to 1373 864 to 2       863/888
(97 %)
5 diff
(99.5 %id)
CD633148   .a 511 to 1220 8 to 716       709/717
(98 %)
9 diff
(98.8 %id)
CD633149   .a 548 to 1368 818 to 1       818/819
(99 %)
6 diff
(99.3 %id)
CD633140   .a 549 to 914 1 to 366       366/367
(99 %)
1 diff
(99.8 %id)
CD633141   .a 549 to 914 366 to 1       366/366
(100 %)
0 diff
(100 %id)
BP368261 thymus .a 565 to 1148 1 to 584       584/584
(100 %)
0 diff
(100 %id)
DA532276 brain .a 613 to 1173 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
BM785509 stomach .a 651 to 1203 1 to 555       555/555
(100 %)
1 diff
(99.9 %id)
BM795420 stomach .a 651 to 1234 1 to 586       586/586
(100 %)
1 diff
(99.9 %id)
CO396945 Chondrosarcoma Lung Metastasis cell lines, lung .a 666 to 1403 9 to 743       735/745
(98 %)
13 diff
(98.3 %id)
BM467107 eye, retinoblastoma .a 677 to 1406 29 to 762       734/1097
(66 %)
15 diff
(98.7 %id)
BQ374827 testis_normal .a 695 to 987 294 to 5       290/297
(97 %)
2 diff
(99.4 %id)
CU446871 epidermis .a 720 to 1383 675 to 12     Submitted on the opposite strand 664/692
(95 %)
1 diff
(99.9 %id)
DA911408   .a 794 to 1340 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
BE257296 eye, retinoblastoma .a 795 to 1374 1 to 580       580/580
(100 %)
0 diff
(100 %id)
CD633131   .a 800 to 902 1 to 103       103/104
(99 %)
1 diff
(99.1 %id)
DA467499 cord Blood .a 818 to 1389 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
CO246090 Chondrosarcoma Lung Metastasis cell lines, lung .a 836 to 1555 8 to 721       714/794
(89 %)
25 diff
(96.9 %id)
AW401390 lymph .a 862 to 1462 1 to 601       601/602
(99 %)
5 diff
(99.2 %id)
TI_154137462   .a 868 to 1571 77 to 782       706/829
(85 %)
21 diff
(97.5 %id)
DR159389 human embryonic stem cells differentiated toan early endodermal cell type .a 876 to 1625 1 to 750       750/750
(100 %)
1 diff
(99.9 %id)
CD633146   .a 881 to 1376 497 to 1       497/498
(99 %)
3 diff
(99.4 %id)
BE536664 cervix .a 883 to 1643 1 to 761       761/810
(93 %)
30 diff
(96.3 %id)
BG760697 melanotic melanoma, high MDR (cell line), skin .a 953 to 1710 1 to 761       761/761
(100 %)
25 diff
(96.8 %id)
BG764785 melanotic melanoma, high MDR (cell line), skin .a 953 to 1674 1 to 725       725/898
(80 %)
25 diff
(97.3 %id)
DA735392   .a 956 to 1686 2 to 738   capped   737/760
(96 %)
13 diff
(98.3 %id)
DA388147 thalamus .a 957 to 1550 2 to 596   capped   595/595
(100 %)
3 diff
(99.5 %id)
AA134678   .a 986 to 1179 1 to 194       194/194
(100 %)
8 diff
(95.9 %id)
DA033540   .a 1028 to 1600 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
BF798508 colon_ins .a 1028 to 1307 285 to 5     Submitted on the opposite strand 281/299
(93 %)
1 diff
(99.7 %id)
BG437827 large cell carcinoma, lung .a 1035 to 1587 1 to 565       565/822
(68 %)
22 diff
(97.4 %id)
BF982422 duodenal adenocarcinoma, cell line, small intestine .a 1096 to 1791 1 to 693       693/889
(77 %)
7 diff
(99.3 %id)
DA505338 brain .a 1141 to 1702 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
BP252335 Kidney .a 1183 to 1760 1 to 578       578/578
(100 %)
0 diff
(100 %id)
DA783619 brain .a 1211 to 1681 2 to 473   capped   472/472
(100 %)
1 diff
(99.8 %id)
AB073663   .a 1218 to 3608 1 to 2391       2391/2395
(99 %)
4 diff
(99.9 %id)
BI046612 prostate_normal .a 1238 to 1693 1 to 464       462/467
(98 %)
24 diff
(94.9 %id)
AI939391 anaplastic oligodendroglioma, brain .a 1241 to 1892 663 to 12   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 650/667
(97 %)
16 diff
(97.7 %id)
BM686896 eye, optic nerve .a 1260 to 1756 1 to 497     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 497/497
(100 %)
5 diff
(99.0 %id)
BM543319 duodenal adenocarcinoma, cell line, small intestine .a 1275 to 2045 13 to 786       774/1064
(72 %)
13 diff
(98.8 %id)
DA593840 lung .a 1342 to 1609 2 to 269   capped   268/268
(100 %)
0 diff
(100 %id)
CV814363 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 1343 to 1791 1 to 450       450/597
(75 %)
5 diff
(99.2 %id)
BU192648 eye, retinoblastoma .a 1361 to 2048 24 to 716       693/912
(75 %)
13 diff
(98.6 %id)
CN365541 embryonic stem cells, DMSO-treated H9 cellline .a 1362 to 1608 1 to 247       247/247
(100 %)
0 diff
(100 %id)
CN365540 embryonic stem cells, DMSO-treated H9 cellline .a 1366 to 1722 1 to 357       357/357
(100 %)
4 diff
(98.9 %id)
BG107130 lymph, lymphoma, cell line .a 1369 to 1895 1 to 530       530/593
(89 %)
8 diff
(98.7 %id)
DA793697 brain .a 1387 to 1934 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
BQ069072 brain, neuroblastoma, cell line .a 1430 to 2044 1 to 616   AAA   616/1155
(53 %)
4 diff
(99.7 %id)
DA085762 cerebellum .a 1443 to 2016 2 to 575   capped   574/574
(100 %)
3 diff
(99.5 %id)
BF736573 bladder_tumor .a 1475 to 1769 298 to 6     Submitted on the opposite strand 293/298
(98 %)
0 diff
(100 %id)
DA363398 subthalamic nucleus .a 1484 to 2047 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
BP202938 coronary artery .a 1489 to 2045 1 to 557       557/559
(99 %)
6 diff
(99.0 %id)
DB053420 testis .a 1489 to 2045 2 to 560   capped   559/563
(99 %)
5 diff
(99.2 %id)
CX754235 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 1517 to 2046 36 to 564     Submitted on the opposite strand 529/564
(93 %)
7 diff
(98.8 %id)
BF800288 colon_ins .a 1679 to 1982 305 to 3     Submitted on the opposite strand 303/307
(98 %)
1 diff
(99.7 %id)
BF800292 colon_ins .a 1679 to 2008 337 to 8     Submitted on the opposite strand 330/337
(97 %)
1 diff
(99.8 %id)
BG421740 Kidney, renal cell adenocarcinoma .a 1726 to 2054 1 to 334       334/709
(47 %)
12 diff
(98.4 %id)
AW411117 muscle, rhabdomyosarcoma .a 1743 to 2035 10 to 302     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 293/302
(97 %)
7 diff
(97.7 %id)
BF305464 muscle, rhabdomyosarcoma .a 1761 to 2425 1 to 566       528/950
(55 %)
55 diff
(94.3 %id)
CD633142   .a 1772 to 1947 1 to 177       177/177
(100 %)
1 diff
(99.5 %id)
CD633143   .a 1772 to 1941 172 to 6       167/172
(97 %)
0 diff
(100 %id)
CD672871 eye, Iris .a 1819 to 2047 1 to 229       229/229
(100 %)
1 diff
(99.6 %id)
CB216497 normal endometrium, mid-secretory phase,cycle day 23, uterus .a 1827 to 2030 1 to 204       204/204
(100 %)
1 diff
(99.6 %id)
CX751481 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 1835 to 2046 1 to 212     Submitted on the opposite strand 212/215
(98 %)
2 diff
(99.1 %id)
CN481725 eye .a 1846 to 2046 1 to 201       201/201
(100 %)
1 diff
(99.6 %id)
DR761892 embryonic stem .a 1867 to 2044 10 to 187       178/187
(95 %)
7 diff
(96.3 %id)
BF725332 eye, Iris .a 1893 to 2044 1 to 152       152/152
(100 %)
2 diff
(98.7 %id)
BP217799 caudate nucleus .a 2122 to 2713 1 to 592       592/592
(100 %)
7 diff
(98.9 %id)
R14738 whole brain .a 2171 to 2375 1 to 205       205/205
(100 %)
3 diff
(98.6 %id)
R12452 whole brain .a 2172 to 2375 1 to 203       203/203
(100 %)
2 diff
(99.1 %id)
R12547 whole brain .a 2190 to 2327 1 to 138     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 138/138
(100 %)
4 diff
(97.2 %id)
BM728904 eye, fetal eye .a 2356 to 2687 1 to 332     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 332/337
(98 %)
1 diff
(99.8 %id)
BU175019 epidermoid carcinoma, cell line, salivary gland .a 2395 to 3129 1 to 737       737/942
(78 %)
17 diff
(98.2 %id)
BQ880748 epidermoid carcinoma, cell line, salivary gland .a 2395 to 3047 1 to 655       655/947
(69 %)
6 diff
(99.4 %id)
CV029866 mixed .a 2397 to 2610 1 to 214       214/214
(100 %)
2 diff
(99.1 %id)
BI223227 cervical carcinoma cell line, cervix .a 2485 to 3095 1 to 607       607/607
(100 %)
4 diff
(99.4 %id)
BM473049 leiomyosarcoma, uterus .a 2489 to 3124 31 to 670       640/1220
(52 %)
18 diff
(98.6 %id)
BG389721 embryonal carcinoma, cell line, testis .a 2551 to 3376 1 to 816       816/1082
(75 %)
31 diff
(97.2 %id)
BI913826 brain .a 2584 to 3322 1 to 736       736/947
(77 %)
24 diff
(97.5 %id)
TI_57243385   .a 2584 to 3322 31 to 766       736/977
(75 %)
24 diff
(97.6 %id)
BX406638 fetal liver, Liver .a 2609 to 3568 952 to 1       952/952
(100 %)
17 diff
(98.3 %id)
BG928028 cartilage .a 2638 to 3173 55 to 597       543/602
(90 %)
11 diff
(98.2 %id)
BF309331 muscle, rhabdomyosarcoma .a 2641 to 3433 1 to 769       769/961
(80 %)
64 diff
(93.4 %id)
BM700923 eye, human retina .a 2709 to 3090 9 to 390     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 382/400
(95 %)
1 diff
(99.8 %id)
BQ221029 embryonal carcinoma, cell line, testis .a 2713 to 3188 1 to 486       486/1100
(44 %)
13 diff
(98.9 %id)
CN365543 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2739 to 3265 1 to 527       527/527
(100 %)
6 diff
(98.9 %id)
BI084637 epidermoid carcinoma, cell line, salivary gland .a 2762 to 3525 787 to 22       766/788
(97 %)
36 diff
(95.5 %id)
BE543467 cervical carcinoma cell line, cervix .a 2778 to 3524 1 to 741       741/932
(79 %)
39 diff
(95.9 %id)
BU166502 melanotic melanoma, cell line, skin .a 2779 to 3518 1 to 741       741/949
(78 %)
19 diff
(98.0 %id)
AI469926 pooled .a 2780 to 3142 363 to 1       363/363
(100 %)
1 diff
(99.8 %id)
BE743433 adenocarcinoma cell line, ovary .a 2787 to 3437 1 to 651       651/654
(99 %)
13 diff
(98.1 %id)
BM702057 eye, optic nerve .a 2865 to 3549 1 to 683       683/683
(100 %)
6 diff
(99.2 %id)
BU855799 ovary, teratocarcinoma, cell line .a 2878 to 3607 768 to 31   AAA Submitted on the opposite strand 738/930
(79 %)
8 diff
(99.2 %id)
AW411118 muscle, rhabdomyosarcoma .a 2882 to 3295 454 to 41   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 414/414
(100 %)
0 diff
(100 %id)
AL120553 amygdala .a 2899 to 3172 13 to 286   fully sequenced,   274/274
(100 %)
1 diff
(99.7 %id)
AJ713390 bone marrow .a 2920 to 3297 1 to 378       378/383
(98 %)
1 diff
(99.8 %id)
AU252709 neuroblastoma .a 2928 to 3607 699 to 17   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 683/684
(99 %)
28 diff
(96.0 %id)
BM999847 Fibrosarcoma .a 2935 to 3607 692 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 674/674
(100 %)
4 diff
(99.5 %id)
R37449 whole brain .a 2943 to 3364 432 to 12   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 421/421
(100 %)
11 diff
(97.4 %id)
H30533 eye, retina .a 2946 to 3348 420 to 18       403/420
(95 %)
0 diff
(100 %id)
AW190512 adenocarcinoma, Pancreas .a 2947 to 3122 176 to 1       176/176
(100 %)
5 diff
(97.2 %id)
BE833051 ovary .a 2952 to 3073 1 to 125       125/136
(91 %)
9 diff
(93.4 %id)
BQ009070 Chondrosarcoma, Left Pubic Bone .a 2954 to 3595 657 to 15   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 643/643
(100 %)
3 diff
(99.6 %id)
BU742923 eye, fetal eye .a 2961 to 3618 678 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 660/660
(100 %)
5 diff
(99.3 %id)
BQ015991 lung, Metastatic Chondrosarcoma .a 2985 to 3607 642 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 624/624
(100 %)
4 diff
(99.4 %id)
T39760 fetal spleen, Spleen .a 3023 to 3223 1 to 202       202/202
(100 %)
1 diff
(99.6 %id)
T39826 fetal spleen, Spleen .a 3024 to 3231 1 to 208       208/208
(100 %)
0 diff
(100 %id)
BX116067 breast .a 3026 to 3603 1 to 578       578/578
(100 %)
1 diff
(99.9 %id)
R48357 breast .a 3026 to 3344 1 to 324   fully sequenced,   324/324
(100 %)
6 diff
(98.2 %id)
BP429751   .a 3030 to 3393 16 to 380       365/380
(96 %)
6 diff
(98.5 %id)
ES309050 occipital hair of pubic hypotrichosispatient, skin .a 3041 to 3517 1 to 477       477/477
(100 %)
0 diff
(100 %id)
BU625301 cell lines, Enchondroma .a 3042 to 3610 588 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 570/570
(100 %)
2 diff
(99.7 %id)
R37338 whole brain .a 3090 to 3364 288 to 11       278/288
(96 %)
0 diff
(100 %id)
CA502945 Human Lung Epithelial cells, lung .a 3099 to 3595 511 to 15   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 497/506
(98 %)
1 diff
(99.9 %id)
AI826007 normal prostate, Prostate .a 3104 to 3591 488 to 1       488/488
(100 %)
4 diff
(99.2 %id)
AA813022   .a 3114 to 3614 502 to 3       500/502
(99 %)
0 diff
(100 %id)
AA703255 liver and spleen .a 3124 to 3597 474 to 1       474/474
(100 %)
6 diff
(98.8 %id)
AL120554 amygdala .a 3142 to 3593 458 to 1   fully sequenced,   458/458
(100 %)
7 diff
(98.5 %id)
AA625853   .a 3142 to 3594 453 to 1       453/453
(100 %)
5 diff
(98.9 %id)
AA719280   .a 3145 to 3597 456 to 3       454/456
(99 %)
0 diff
(100 %id)
AI272168 brain, oligodendroglioma .a 3162 to 3570 411 to 3       409/414
(98 %)
0 diff
(100 %id)
AI870257 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 3165 to 3610 455 to 10       446/455
(98 %)
0 diff
(100 %id)
AI952791 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 3172 to 3596 425 to 1       425/425
(100 %)
0 diff
(100 %id)
BF940978 brain, oligodendroglioma .a 3174 to 3610 438 to 2       437/438
(99 %)
0 diff
(100 %id)
AW051999 pooled .a 3180 to 3597 421 to 4       418/421
(99 %)
0 diff
(100 %id)
AA053159 colon, tumor .a 3193 to 3332 1 to 141   fully sequenced,   141/141
(100 %)
1 diff
(99.3 %id)
DB367645   .a 3193 to 3618 430 to 1       430/555
(77 %)
6 diff
(99.0 %id)
AI082139   .a 3201 to 3598 405 to 9       397/405
(98 %)
0 diff
(100 %id)
AI125671   .a 3201 to 3594 394 to 1       394/394
(100 %)
2 diff
(99.5 %id)
AW104742 ovary, tumor, 5 pooled (see description) .a 3202 to 3595 395 to 1       395/395
(100 %)
9 diff
(97.8 %id)
T98866 liver and spleen .a 3203 to 3595 409 to 9       401/412
(97 %)
0 diff
(100 %id)
BP390599 pancreatic islet .a 3218 to 3595 1 to 378     Submitted on the opposite strand 378/378
(100 %)
1 diff
(99.8 %id)
AA308837 aorta .a 3221 to 3476 1 to 256       256/256
(100 %)
1 diff
(99.7 %id)
AW952069   .a 3222 to 3595 1 to 374   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 374/374
(100 %)
4 diff
(99.0 %id)
AA928937 carcinoid, lung .a 3225 to 3603 384 to 8       377/384
(98 %)
0 diff
(100 %id)
AI921451 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 3227 to 3610 412 to 29   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 384/384
(100 %)
8 diff
(98.0 %id)
AA340417 brain .a 3232 to 3486 1 to 255       255/255
(100 %)
1 diff
(99.7 %id)
R44512 whole brain .a 3234 to 3609 390 to 9       382/397
(96 %)
0 diff
(100 %id)
BM672268 eye, human retina .a 3236 to 3613 396 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 378/378
(100 %)
2 diff
(99.5 %id)
H16246 whole brain .a 3240 to 3607 382 to 13   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 370/370
(100 %)
7 diff
(98.2 %id)
AA833602   .a 3247 to 3610 370 to 9       362/370
(97 %)
0 diff
(100 %id)
AA364915 pineal body .a 3248 to 3526 1 to 279       279/279
(100 %)
1 diff
(99.7 %id)
CN365542 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3266 to 3597 1 to 332       332/333
(99 %)
5 diff
(98.5 %id)
T40772 fetal spleen, Spleen .a 3272 to 3610 347 to 2       346/350
(98 %)
0 diff
(100 %id)
BF082449 breast .a 3278 to 3414 29 to 166       138/166
(83 %)
6 diff
(96.4 %id)
AW104741 ovary, tumor, 5 pooled (see description) .a 3278 to 3595 319 to 1       319/319
(100 %)
16 diff
(95.0 %id)
BM673100 eye, optic nerve .a 3284 to 3611 346 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 328/328
(100 %)
1 diff
(99.7 %id)
AA350537 brain .a 3302 to 3595 294 to 1       294/294
(100 %)
1 diff
(99.7 %id)
AA053022 colon, tumor .a 3302 to 3613 314 to 1   fully sequenced,   314/314
(100 %)
2 diff
(99.4 %id)
AI928736 anaplastic oligodendroglioma, brain .a 3305 to 3597 298 to 6       293/298
(98 %)
0 diff
(100 %id)
AI453416 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 3308 to 3609 302 to 1       302/302
(100 %)
0 diff
(100 %id)
AI933170 anaplastic oligodendroglioma, brain .a 3312 to 3597 287 to 2       286/287
(99 %)
0 diff
(100 %id)
R48258 breast .a 3314 to 3609 302 to 1   fully sequenced,   302/302
(100 %)
9 diff
(97.1 %id)
AA740797 2 pooled tumors (clear cell type), Kidney .a 3314 to 3552 237 to 1       237/237
(100 %)
1 diff
(99.6 %id)
AI784134 pooled .a 3349 to 3597 252 to 4       249/252
(98 %)
0 diff
(100 %id)
AA350621 brain .a 3350 to 3609 261 to 1       261/261
(100 %)
2 diff
(99.3 %id)
BG056917 anaplastic oligodendroglioma, brain .a 3357 to 3610 255 to 2       254/255
(99 %)
0 diff
(100 %id)
AI240679 liver and spleen .a 3358 to 3607 284 to 35   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 250/250
(100 %)
8 diff
(96.8 %id)
AA907088 carcinoid, lung .a 3428 to 3552 125 to 1       125/131
(95 %)
0 diff
(100 %id)
N86840   .a 3473 to 3614 1 to 141       141/143
(98 %)
2 diff
(98.7 %id)
AW071136 breast, four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary .a 3503 to 3610 108 to 1       108/113
(95 %)
1 diff
(99.2 %id)
BE156300 head_neck .a 3899 to 4450 1 to 551       551/551
(100 %)
6 diff
(99.0 %id)
DB100014 testis .b 1 to 452 2 to 453   tiling clone, capped   452/452
(100 %)
1 diff
(99.8 %id)
DB091838 testis .b 33 to 301 2 to 270   capped   269/272
(98 %)
2 diff
(99.3 %id)
AB088047   .b 34 to 3560 1 to 3528 F70S tiling clone,   3528/3529
(99 %)
4 diff
(99.9 %id)
DR003494 heart .b 101 to 768 1 to 667       667/667
(100 %)
9 diff
(98.7 %id)
CA392764 eye, RPE/choroid .b 120 to 397 1 to 278       278/278
(100 %)
3 diff
(99.0 %id)
DA340479 hippocampus .b 212 to 797 2 to 587   capped   586/586
(100 %)
1 diff
(99.9 %id)
CR735310 lymph, lymphoma, cell line .b 278 to 795 9 to 526       518/526
(98 %)
7 diff
(98.7 %id)
CR735473 lymph, lymphoma, cell line .b 278 to 786 38 to 547       510/547
(93 %)
8 diff
(98.6 %id)
BQ066239 lymph, lymphoma, cell line .b 279 to 1130 1 to 858       858/1020
(84 %)
22 diff
(97.9 %id)
AK075272 thyroid gland .b 295 to 3248 1 to 2954   tiling clone, available from FLJ,   2954/2954
(100 %)
2 diff
(100.0 %id)
DB166464 thyroid gland .b 296 to 1037 2 to 744   capped   743/743
(100 %)
10 diff
(98.7 %id)
BQ709130 Spleen .b 301 to 1191 1 to 907       902/919
(98 %)
24 diff
(97.4 %id)
BX403141 Neuroblastoma Cot 25-normalized .b 313 to 1115 1 to 803       803/803
(100 %)
6 diff
(99.3 %id)
AY057448 brain .b 319 to 3548 1 to 3226       3226/3226
(100 %)
13 diff
(99.6 %id)
AY120867 brain .b 331 to 2984 1 to 2650       2650/2650
(100 %)
5 diff
(99.9 %id)
AK027619   .b 988 to 3571 1 to 2583   tiling clone, available from FLJ,   2583/2583
(100 %)
4 diff
(99.9 %id)
BF309029 muscle, rhabdomyosarcoma .b 1794 to 2625 1 to 838       782/1009
(77 %)
79 diff
(92.2 %id)
BE299947 muscle, rhabdomyosarcoma .b 1797 to 2534 1 to 735       735/963
(76 %)
14 diff
(98.6 %id)
BG394260 eye, retinoblastoma .b 1839 to 2490 1 to 649       649/795
(81 %)
22 diff
(97.3 %id)
BI196702 brain, neuroblastoma .b 1958 to 2670 1 to 715       715/718
(99 %)
25 diff
(96.6 %id)
AI905651 breast .b 2184 to 2394 20 to 231       212/259
(81 %)
12 diff
(95.4 %id)
BG744466 blood, natural killer cells, cell line .b 2184 to 2758 1 to 579   fully sequenced,   579/579
(100 %)
12 diff
(98.0 %id)
BU556772 ovary, teratocarcinoma, cell line .b 2187 to 3050 1 to 871       871/919
(94 %)
25 diff
(97.3 %id)
BU556931 ovary, teratocarcinoma, cell line .b 2187 to 2955 1 to 771       771/974
(79 %)
15 diff
(98.5 %id)
BE299576 muscle, rhabdomyosarcoma .b 2564 to 3221 675 to 16       660/675
(97 %)
0 diff
(100 %id)
BX386948 Neuroblastoma Cot 25-normalized .b 2595 to 3540 939 to 1       939/960
(97 %)
43 diff
(95.6 %id)
BG745114 blood, natural killer cells, cell line .b 2728 to 3513 786 to 1   fully sequenced,   786/786
(100 %)
3 diff
(99.7 %id)
DB382513 thyroid gland .b 2742 to 3248 506 to 1       506/511
(99 %)
10 diff
(98.1 %id)
BQ881803 dorsal root ganglia .c 1 to 581 74 to 656   tiling clone,   583/1203
(48 %)
15 diff
(98.8 %id)
AK074578 whole embryo, mainly head .c 404 to 2427 1 to 2024   tiling clone, available from FLJ,   2024/2024
(100 %)
1 diff
(100.0 %id)
BF308510 muscle, rhabdomyosarcoma .c 1565 to 2351 1 to 778       778/825
(94 %)
18 diff
(97.9 %id)
DC400319 testis .d 1 to 550 1 to 550   tiling clone,   550/550
(100 %)
1 diff
(99.9 %id)
BQ951442 epidermoid carcinoma, cell line, lung .e 1 to 853 1 to 860   tiling clone,   860/878
(97 %)
10 diff
(98.9 %id)
BQ960397 epidermoid carcinoma, cell line, lung .e 1 to 303 1 to 306       306/1115
(27 %)
4 diff
(99.7 %id)
AI202873 anaplastic oligodendroglioma, brain .e 574 to 864 327 to 37   tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 291/327
(88 %)
2 diff
(99.4 %id)
AI869600 anaplastic oligodendroglioma, brain .e 593 to 868 309 to 33   tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 277/311
(89 %)
4 diff
(98.8 %id)
TI_57180627   .f 1 to 753 60 to 813   tiling clone,   754/813
(92 %)
11 diff
(98.7 %id)
BI768176 pooled lung and spleen .f 10 to 753 1 to 746       746/746
(100 %)
4 diff
(99.5 %id)
CR996561 T-Lymphocytes .f 338 to 935 1 to 598   tiling clone,   598/598
(100 %)
1 diff
(99.9 %id)
DB143366 thymus .g-u 1 to 479 2 to 480   tiling clone, capped   479/479
(100 %)
0 diff
(100 %id)
BF059085 fibrotheoma, ovary .g-u 84 to 653 570 to 1       570/570
(100 %)
0 diff
(100 %id)
TI_154090266   .g-u 119 to 653 614 to 76       539/722
(74 %)
0 diff
(100 %id)
AI798038 B-cell, chronic lymphotic leukemia .g-u 233 to 624 392 to 1       392/392
(100 %)
0 diff
(100 %id)
TI_2016724783   .g-u 426 to 1161 44 to 783 Q150*     740/963
(76 %)
11 diff
(98.9 %id)
TI_2016730503   .g-u 426 to 1161 40 to 777 exact     738/1247
(59 %)
5 diff
(99.6 %id)
BC151151 Testicle, PCR rescued clones .g-u 430 to 1161 1 to 732 exact     732/732
(100 %)
2 diff
(99.8 %id)
BC151152 Brain, cerebral cortex, PCR rescued clones .g-u 432 to 1161 1 to 730 exact tiling clone,   730/730
(100 %)
1 diff
(99.9 %id)
TI_2016727237   .g-u 434 to 938 52 to 559       508/561
(90 %)
25 diff
(95.6 %id)
NM_212550.3   .h 1 to 2599 1 to 2599 exact RefSeq, AAA   2599/2599
(100 %)
0 diff
(100 %id)
DC422050 uterus .h 1 to 545 1 to 545 exact tiling clone,   545/545
(100 %)
0 diff
(100 %id)
AK296695 tongue, tumor tissue .h 3 to 1376 1 to 1374   tiling clone,   1374/1374
(100 %)
3 diff
(99.8 %id)
DC345549 tongue, tumor tissue .h 3 to 529 1 to 527       527/527
(100 %)
2 diff
(99.7 %id)
DC316299 amygdala .h 7 to 256 1 to 250       250/250
(100 %)
0 diff
(100 %id)
DN996082 breast cancer, Mammary gland (cancer tissue) .h 21 to 588 1 to 570       570/570
(100 %)
7 diff
(98.8 %id)
DC375127 brain .h 29 to 346 1 to 318       318/318
(100 %)
1 diff
(99.7 %id)
BF313251 brain, neuroblastoma .h 53 to 778 1 to 729       729/730
(99 %)
28 diff
(96.2 %id)
BE382412 brain, neuroblastoma .h 73 to 725 1 to 651       651/655
(99 %)
8 diff
(98.8 %id)
AY531266 brain .h 97 to 705 1 to 609       609/609
(100 %)
0 diff
(100 %id)
AI817656 colon, colon tumor, RER+ .h 469 to 791 1 to 323     Submitted on the opposite strand 323/323
(100 %)
0 diff
(100 %id)
AI917188 pooled germ cell tumors .h 469 to 830 1 to 362     Submitted on the opposite strand 362/362
(100 %)
0 diff
(100 %id)
AI766521 colon, colon tumor, RER+ .h 469 to 781 1 to 314     Submitted on the opposite strand 314/314
(100 %)
1 diff
(99.7 %id)
AI860942 anaplastic oligodendroglioma, brain .h 469 to 967 1 to 500     Submitted on the opposite strand 500/500
(100 %)
2 diff
(99.6 %id)
AW003029 pooled germ cell tumors .h 469 to 885 1 to 417     Submitted on the opposite strand 417/417
(100 %)
0 diff
(100 %id)
AI968875 pooled germ cell tumors .h 469 to 813 1 to 345     Submitted on the opposite strand 345/345
(100 %)
0 diff
(100 %id)
AW197592 pooled germ cell tumors .h 469 to 885 1 to 417     Submitted on the opposite strand 417/417
(100 %)
0 diff
(100 %id)
BE549855 pooled germ cell tumors .h 469 to 885 1 to 417     Submitted on the opposite strand 417/417
(100 %)
2 diff
(99.6 %id)
BE672856 Prostate .h 469 to 791 1 to 323     Submitted on the opposite strand 323/323
(100 %)
0 diff
(100 %id)
AW291673   .h 470 to 888 1 to 419     Submitted on the opposite strand 419/419
(100 %)
0 diff
(100 %id)
BF063200 colon, colon tumor, RER+ .h 471 to 777 1 to 307     Submitted on the opposite strand 307/307
(100 %)
2 diff
(99.4 %id)
BF434644 fibrotheoma, ovary .h 478 to 1010 1 to 533     Submitted on the opposite strand 533/533
(100 %)
0 diff
(100 %id)
AI684331 B-cell, chronic lymphotic leukemia .h 513 to 800 1 to 288     Submitted on the opposite strand 288/288
(100 %)
2 diff
(99.4 %id)
AK130186   .h 722 to 2598 1 to 1877   available from FLJ,   1877/1877
(100 %)
2 diff
(99.9 %id)
BC040703 Duodenum, adenocarcinoma .h 1036 to 2600 1576 to 12   available from MGC, AAA Submitted on the opposite strand 1565/1609
(97 %)
0 diff
(100 %id)
BQ072295 brain, neuroblastoma, cell line .h 1036 to 1966 24 to 958   tiling clone,   935/995
(93 %)
37 diff
(96.3 %id)
AW794606 uterus .h 1065 to 1492 425 to 1       425/425
(100 %)
3 diff
(99.3 %id)
AW794607 uterus .h 1066 to 1501 439 to 7       433/440
(98 %)
0 diff
(100 %id)
AA451988   .h 1074 to 1557 483 to 2     Submitted on the opposite strand 482/483
(99 %)
0 diff
(100 %id)
AK130151   .h 1160 to 2599 1 to 1440   tiling clone, available from FLJ,   1440/1440
(100 %)
0 diff
(100 %id)
R72314 breast .h 1165 to 1575 1 to 414       414/439
(94 %)
9 diff
(98.0 %id)
CU451850 epidermis .h 1176 to 1495 12 to 331       320/348
(91 %)
1 diff
(99.8 %id)
AW867225 stomach_normal .h 1235 to 1485 1 to 252       252/262
(96 %)
11 diff
(95.9 %id)
R48756 breast .h 1241 to 1639 1 to 409       409/449
(91 %)
18 diff
(96.0 %id)
CF596843 ovary .h 1333 to 1959 1 to 635       635/948
(66 %)
16 diff
(98.4 %id)
BP872324 embryonal kidney .h 1540 to 2139 1 to 599       599/599
(100 %)
1 diff
(99.9 %id)
CB132267 Liver .h 1540 to 1975 1 to 436       436/436
(100 %)
0 diff
(100 %id)
CB142858 Liver .h 1540 to 2068 1 to 529       529/529
(100 %)
0 diff
(100 %id)
BG260049 bladder, transitional cell papilloma, cell line .h 1554 to 2328 1 to 768       768/768
(100 %)
12 diff
(98.5 %id)
BM554742 duodenal adenocarcinoma, cell line, small intestine .h 1622 to 2600 1057 to 65   available from MGC, Submitted on the opposite strand 993/1083
(91 %)
0 diff
(100 %id)
BQ896885 epidermoid carcinoma, cell line, salivary gland .h 1720 to 2599 1 to 885       885/988
(89 %)
13 diff
(98.7 %id)
BF795252 lymph, lymphoma, cell line .h 1789 to 2598 805 to 1     Submitted on the opposite strand 805/815
(98 %)
40 diff
(95.1 %id)
BU616355 Bone, Subchondral Bone .h 1922 to 2599 695 to 19   AAA   677/677
(100 %)
2 diff
(99.8 %id)
BQ184431 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h 1942 to 2599 676 to 19   AAA   658/673
(97 %)
0 diff
(100 %id)
BI905960 leukocyte .h 1947 to 2599 1 to 653   AAA   653/653
(100 %)
0 diff
(100 %id)
TI_57231849   .h 1947 to 2599 35 to 687   AAA   653/687
(95 %)
6 diff
(99.2 %id)
BF110920 carcinoid, lung .h 2000 to 2543 1 to 541     Submitted on the opposite strand 541/541
(100 %)
12 diff
(97.8 %id)
BF062383 pooled germ cell tumors .h 2065 to 2600 536 to 1       536/536
(100 %)
0 diff
(100 %id)
BP395134 pancreatic islet .h 2098 to 2600 1 to 503     Submitted on the opposite strand 503/507
(99 %)
1 diff
(99.9 %id)
BQ013663 placenta .h 2126 to 2599 489 to 18   AAA   472/472
(100 %)
2 diff
(99.6 %id)
BF515258   .h 2132 to 2599 485 to 18   AAA   468/468
(100 %)
0 diff
(100 %id)
AI150441   .h 2159 to 2599 457 to 17   AAA   441/441
(100 %)
1 diff
(99.8 %id)
AA156531 colon, tumor .h 2173 to 2599 452 to 27   AAA   426/426
(100 %)
1 diff
(99.8 %id)
AW882476 ovary .h 2185 to 2346 7 to 167       161/177
(90 %)
5 diff
(97.2 %id)
AI828850 pooled germ cell tumors .h 2194 to 2599 406 to 1       406/406
(100 %)
0 diff
(100 %id)
AI808647 pooled .h 2203 to 2600 401 to 4       398/401
(99 %)
0 diff
(100 %id)
BF431122 Kidney .h 2242 to 2599 358 to 1       358/358
(100 %)
0 diff
(100 %id)
F20450 pectoral muscle (after mastectomy) .h 2244 to 2600 1 to 357       357/357
(100 %)
2 diff
(99.5 %id)
AI202061 anaplastic oligodendroglioma, brain .h 2258 to 2487 230 to 1       230/230
(100 %)
0 diff
(100 %id)
BE044591 pooled .h 2264 to 2600 339 to 3       337/339
(99 %)
0 diff
(100 %id)
CU454173 epidermis .h 2303 to 2463 14 to 173       160/174
(91 %)
8 diff
(95.5 %id)
AW182069 pooled .h 2322 to 2599 288 to 11   AAA   278/278
(100 %)
1 diff
(99.7 %id)
AW272278 colon, moderately-differentiated adenocarcinoma .h 2337 to 2600 265 to 2       264/265
(99 %)
0 diff
(100 %id)
AW607927 head_neck .h 2348 to 2527 9 to 188       180/191
(94 %)
8 diff
(95.9 %id)
AA436323 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h 2490 to 2601 1 to 112   tiling clone, fully sequenced, AAA   112/112
(100 %)
0 diff
(100 %id)
BY999277   .h 2529 to 2600 1 to 72     Submitted on the opposite strand 72/74
(97 %)
1 diff
(98.7 %id)
D21007   .h 2529 to 2600 1 to 72     Submitted on the opposite strand 72/74
(97 %)
1 diff
(98.7 %id)
AA436198 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h 2547 to 2601 55 to 1   fully sequenced,   55/55
(100 %)
0 diff
(100 %id)
BQ363762 stomach .i 1 to 625 17 to 639   tiling clone,   623/639
(97 %)
7 diff
(99.0 %id)
BQ309262 breast .i 453 to 751 12 to 319   tiling clone,   308/320
(96 %)
20 diff
(93.8 %id)
BQ309469 breast .i 453 to 751 12 to 319       308/320
(96 %)
20 diff
(93.8 %id)
AA069668   .j-u 1 to 419 420 to 1   tiling clone,   420/420
(100 %)
1 diff
(99.8 %id)
DA568862 whole embryo, mainly head .j-u 17 to 692 2 to 677   tiling clone, capped   676/676
(100 %)
1 diff
(99.9 %id)
H50446 brain .j-u 538 to 771 1 to 234   tiling clone,   234/235
(99 %)
5 diff
(97.9 %id)
DB355432 whole embryo, mainly head .j-u 1252 to 1794 539 to 1   tiling clone,   539/542
(99 %)
14 diff
(97.5 %id)
H50447 brain .j-u 1377 to 1774 401 to 1   tiling clone,   401/401
(100 %)
5 diff
(98.8 %id)
EL736488 mixed .k 1 to 288 1 to 288 exact tiling clone,   288/475
(60 %)
1 diff
(99.8 %id)
CR737011   .l 1 to 473 1 to 473 exact tiling clone,   473/473
(100 %)
0 diff
(100 %id)
BI024477 marrow .m-u 1 to 181 1 to 179   tiling clone,   179/179
(100 %)
7 diff
(96.1 %id)
BM688092 eye, human retina .m-u 116 to 624 8 to 516   tiling clone,   509/516
(98 %)
6 diff
(98.9 %id)
TI_151698300   .m-u 627 to 971 447 to 103   tiling clone,   345/791
(43 %)
0 diff
(100 %id)
BX098214   .n 1 to 540 1 to 540 exact tiling clone,   540/542
(99 %)
4 diff
(99.3 %id)
AA609292   .n 182 to 538 369 to 13 Q13H G14S AAA   357/357
(100 %)
2 diff
(99.5 %id)
AA759203   .n 206 to 540 339 to 5 Q13H G14S     335/339
(98 %)
2 diff
(99.5 %id)
FN099304 breast carcinoma .n 440 to 561 1 to 123   tiling clone,   123/123
(100 %)
2 diff
(98.4 %id)
AI143668 anaplastic oligodendroglioma, brain .o 1 to 469 1 to 469 exact   Submitted on the opposite strand 469/469
(100 %)
0 diff
(100 %id)
AI363883 anaplastic oligodendroglioma, brain .o 1 to 361 1 to 364     Submitted on the opposite strand 364/364
(100 %)
8 diff
(97.9 %id)
AI360102 anaplastic oligodendroglioma, brain .o 1 to 552 1 to 552 G12X tiling clone, Submitted on the opposite strand 552/552
(100 %)
0 diff
(100 %id)
CD633130   Gene BLOC1S3andMARK4, variant not shown         This clone was ignored    
DB357884 whole embryo, mainly head Gene BLOC1S3andMARK4, variant not shown         This clone was ignored    
DA571061 whole embryo, mainly head Gene BLOC1S3andMARK4, variant not shown       capped This clone was ignored    
AI142585 pooled Gene BLOC1S3andMARK4, variant not shown         Suspected internal deletion, this clone was ignored    
BC009049 Eye, retinoblastoma Gene BLOC1S3andMARK4, variant not shown       available from MGC, AAA Suspected internal deletion, this clone was ignored    
BE784109 eye, retinoblastoma Gene BLOC1S3andMARK4, variant not shown       available from MGC, Suspected internal deletion, this clone was ignored    
BC071948 Ovary, teratocarcinoma Gene BLOC1S3andMARK4, variant not shown       available from MGC, AAA Suspected internal deletion, this clone was ignored    
DA835956 placenta Gene BLOC1S3andMARK4, variant not shown       capped Suspected internal deletion, this clone was ignored    
BM724351 eye, fetal eye Gene BLOC1S3andMARK4, variant not shown         This clone was ignored    
BU741626 eye, fetal eye Gene BLOC1S3andMARK4, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g-u, .h, .i, .j-u, .k, .l, .m-u, .n, .o Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI